These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1303987)

  • 1. Profile of oral contraceptive usage by females of the northern part of West Bengal.
    Tripathi SK; Mandal AK; Dawn G
    Indian J Public Health; 1992; 36(2):55-6. PubMed ID: 1303987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database.
    Szoka PR; Edgren RA
    Fertil Steril; 1988 May; 49(5 Suppl 2):31S-38S. PubMed ID: 3282933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in breast cancer and age at start of oral contraceptive usage.
    Ranstam J; Olsson H; Garne JP; Aspegren K; Janzon L
    Anticancer Res; 1991; 11(6):2043-6. PubMed ID: 1776838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives: Pt. 2.
    Family Planning Association of New South Wales
    Fam Plann Inf Serv; 1978; 1(2):1-36. PubMed ID: 12338652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg.
    Beksinska ME; Rees VH; Nkonyane T; McIntyre JA
    Br J Fam Plann; 1998 Apr; 24(1):21-3. PubMed ID: 9719703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives.
    Rosenberg MJ; Waugh MS; Long S
    J Reprod Med; 1995 May; 40(5):355-60. PubMed ID: 7608875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptives and cardiovascular diseases morbidity].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 May; 54():119-25. PubMed ID: 3732840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response from women to adverse publicity about oral contraceptives.
    Portnoy A
    J R Coll Gen Pract; 1984 Jun; 34(263):334-5. PubMed ID: 6747937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal contraceptive methods.
    McEwan J
    Practitioner; 1985 May; 229(1403):415-23. PubMed ID: 4011568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral contraception and carbohydrate metabolism: III--practical implications].
    Hilal M
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.